維百奧生物代理Neuromab產(chǎn)品

Neuromab是一家由NIH資助成立的單克隆抗體庫(kù)。

The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.

Neuromab的主要產(chǎn)品包括：

Array Tomography

Model Organisms

Disease Targets 

更多詳情請(qǐng)聯(lián)系 

維百奧（北京）生物科技有限公司

全國(guó)服務(wù)熱線：400-001-2615

郵箱：info@vicbio.com

網(wǎng)站：www.vicbio.com